C21 Investments (CXXIF) Research & Development (2018 - 2024)

C21 Investments (CXXIF) has 7 years of Research & Development data on file, last reported at -$22.5 billion in Q1 2024.

• On a quarterly basis, Research & Development changed N/A year-over-year to -$22.5 billion in Q1 2024; TTM through Mar 2024 was $16.0 billion, a N/A change from a year earlier, with the FY2024 full-year figure at $16.0 billion, changed N/A from the prior year.
• Research & Development for Q1 2024 stood at -$22.5 billion, down from $12.9 billion in the prior quarter.
• Over the last five years, Research & Development for CXXIF reached as high as $19.9 billion in Q4 2022 and fell as low as -$22.5 billion in Q1 2024.
• Historically, Research & Development has averaged $5.3 billion across 5 years, with a median of $110547.0 in 2020.
• Across the five-year window, Research & Development sank 92.78% in 2020 and soared 49518062.06% in 2022, its largest moves.
• Year by year, Research & Development stood at $21636.0 in 2020, then jumped by 85.28% to $40088.0 in 2021, then surged by 49518062.06% to $19.9 billion in 2022, then slumped by 35.11% to $12.9 billion in 2023, then sank by 274.51% to -$22.5 billion in 2024.
• Per Business Quant data, the three most recent Research & Development figures were -$22.5 billion in Q1 2024, $12.9 billion in Q4 2023, and $12.9 billion in Q3 2023.